Biosimilars Market Will Grow at Highest Pace Owing to Rising Demand for Cost-Effective Drugs
Biosimilars are biopharmaceutical drugs that are molecularly similar with equivalent therapeutic efficacy and safety as compared to corresponding reference biologics. Biosimilars provide a cost-effective alternate to expensive biologics and expand patient access. With patent expiry of large molecular biologics, biosimilars offer significant cost savings and enable more patients to access...
0 Kommentare 0 Anteile 544 Ansichten 0 Vorschau